Consun Pharmaceutical Group Limited (1681.HK)
HKD 7.63
(-1.68%)
HKD 7.63
(-1.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 818.97 Million | 947.67 Million | 725.53 Million | 867.05 Million | 383.31 Million | 754.21 Million |
| Net Income | 863.7 Million | 682.9 Million | 590.17 Million | 498.78 Million | 79.82 Million | 465.35 Million |
| Depreciation & Amortization | 78.08 Million | 76.35 Million | 72.98 Million | 71.79 Million | 73.11 Million | 68.38 Million |
| Deferred income taxes | - | -57.18 Million | -98.06 Million | -288.11 Million | -41.49 Million | -63.3 Million |
| Stock-based compensation | - | -1.78 Million | 23.41 Million | 12.16 Million | 19.92 Million | 8.49 Million |
| Change in working capital | -29.66 Million | 58.96 Million | 74.65 Million | 275.95 Million | 21.57 Million | 54.81 Million |
| Other non-cash items | -47.65 Million | 188.41 Million | 62.37 Million | 296.47 Million | 230.38 Million | 220.47 Million |
| Investing Cash Flow | -231.77 Million | -368.8 Million | -298.3 Million | -25.7 Million | -110.13 Million | -180.8 Million |
| Investments in PPE | -52.56 Million | -51.58 Million | -98.25 Million | -48.7 Million | -179.74 Million | -193.34 Million |
| Acquisitions | - | 365.67 Million | 230 Million | - | - | - |
| Investment purchases | -557.5 Million | -465.67 Million | -350 Million | - | - | - |
| Sales/Maturities of investments | 309.23 Million | 100 Million | 120 Million | - | - | - |
| Other Investing Activities | -179.2 Million | -317.21 Million | -200.05 Million | 23 Million | 69.61 Million | 12.54 Million |
| Financing Cash Flow | -280.1 Million | -342.2 Million | -166.65 Million | -279.8 Million | -156.66 Million | -292.42 Million |
| Debt repayment | -62.96 Million | -436.67 Million | -235.8 Million | -237.92 Million | -459.96 Million | -197 Million |
| Dividends payments | -326.24 Million | -127.49 Million | -198.07 Million | -131.49 Million | -225.54 Million | -68.94 Million |
| Common Stock Repurchased | - | -29.06 Million | -30.15 Million | -152.74 Million | -46.21 Million | 191.38 Million |
| Common Stock Issuance | 14.2 Million | 2.63 Million | 14.56 Million | 390.66 Million | 2.49 Million | 5.62 Million |
| Other Financing Activities | -13.3 Million | 248.38 Million | 282.81 Million | -148.31 Million | 572.57 Million | -223.48 Million |
| Accounts receivables | -1.7 Million | 113.87 Million | 114.2 Million | 304.45 Million | 25.59 Million | 67.84 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -102.02 Million | -54.9 Million | -39.55 Million | -28.5 Million | -4.02 Million | -13.03 Million |
| Other working capital | -6.24 Million | 3 Million | 18.04 Million | -9.13 Million | - | - |
| Cash at beginning of period | 2.45 Billion | 2.19 Billion | 1.94 Billion | 1.38 Billion | 1.26 Billion | 989.56 Million |
| Cash at end of period | 2.74 Billion | 2.45 Billion | 2.19 Billion | 1.94 Billion | 1.38 Billion | 1.26 Billion |
| Capital Expenditure | -52.56 Million | -51.58 Million | -98.25 Million | -48.7 Million | -179.74 Million | -193.34 Million |
| Effect of forex changes on cash | -9.01 Million | 17.18 Million | -4.52 Million | -4.51 Million | -3.03 Million | -800 Thousand |
| Net cash flow / Change in cash | 298.08 Million | 253.85 Million | 256.05 Million | 557.04 Million | 113.48 Million | 280.18 Million |
| Free Cash Flow | 766.4 Million | 896.09 Million | 627.28 Million | 818.35 Million | 203.56 Million | 560.86 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 399.76 Million | 436.64 Million | 863.7 Million | 347.89 Million | 682.9 Million | 386.17 Million |
| Depreciation & Amortization | 39.86 Million | 39.41 Million | 78.08 Million | 38.67 Million | 76.35 Million | 36.96 Million |
| Deferred income taxes | - | - | - | - | -57.18 Million | - |
| Stock-based compensation | - | - | - | - | -1.78 Million | - |
| Change in working capital | - | -109.96 Million | -29.66 Million | - | 58.96 Million | 61.96 Million |
| Other non-cash items | -89.29 Million | 198.91 Million | -47.65 Million | -132.59 Million | 188.41 Million | 129.82 Million |
| Investing Cash Flow | -159.63 Million | -307.38 Million | -231.77 Million | 75.61 Million | -368.8 Million | -76.94 Million |
| Investments in PPE | -46.92 Million | -35.78 Million | -52.56 Million | -16.77 Million | -51.58 Million | -24.02 Million |
| Acquisitions | - | - | - | - | 365.67 Million | - |
| Investment purchases | - | - | -557.5 Million | - | -465.67 Million | - |
| Sales/Maturities of investments | - | - | 309.23 Million | - | 100 Million | - |
| Other Investing Activities | -112.7 Million | -271.6 Million | -179.2 Million | 92.39 Million | -317.21 Million | -52.91 Million |
| Financing Cash Flow | -341.78 Million | -142.55 Million | -280.1 Million | -137.54 Million | -342.2 Million | -39.97 Million |
| Debt repayment | -1.39 Million | - | -62.96 Million | -72.05 Million | -436.67 Million | - |
| Dividends payments | -450.2 Million | -118.18 Million | -326.24 Million | -208.06 Million | -127.49 Million | - |
| Common Stock Repurchased | - | - | - | - | -29.06 Million | - |
| Common Stock Issuance | - | - | 14.2 Million | - | 2.63 Million | - |
| Other Financing Activities | 107.02 Million | -24.37 Million | -13.3 Million | -1.53 Million | 248.38 Million | -39.97 Million |
| Accounts receivables | - | -1.7 Million | -1.7 Million | - | 113.87 Million | 113.87 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | -102.02 Million | -102.02 Million | - | -54.9 Million | -54.9 Million |
| Other working capital | - | -6.24 Million | -6.24 Million | - | 3 Million | 3 Million |
| Cash at beginning of period | 2.74 Billion | 2.64 Billion | 2.45 Billion | 2.45 Billion | 2.19 Billion | 1.94 Billion |
| Cash at end of period | 2.59 Billion | 2.64 Billion | 2.74 Billion | 2.64 Billion | 2.45 Billion | 2.45 Billion |
| Capital Expenditure | -46.92 Million | -35.78 Million | -52.56 Million | -16.77 Million | -51.58 Million | -24.02 Million |
| Effect of forex changes on cash | -1.26 Million | -10.98 Million | -9.01 Million | 1.97 Million | 17.18 Million | 11.53 Million |
| Net cash flow / Change in cash | -152.34 Million | - | 298.08 Million | 194.02 Million | 253.85 Million | 509.54 Million |
| Free Cash Flow | 303.41 Million | 529.2 Million | 766.4 Million | 237.2 Million | 896.09 Million | 590.9 Million |
000631
AHK
OFSTF
0GN6
016580
RELI